Authors Posts by Jim Sharp

Jim Sharp


The Office of Children, Youth and Families (OCYF) is pleased to announce the continuation of their partnership with the Office of Mental Health & Substance Abuse Services (OMHSAS) in contracting with Lakeside Global Institute to provide PA Child Welfare Professionals FREE trauma training. What is considered a PA Child Welfare Professional? Anyone who serves children and families who live in Pennsylvania. If your work touches on improving the lives of children and families, this applies to you and your organization!

Multiple cohorts for courses and workshops will be facilitated by Lakeside Global Institute and are available until September 30, 2024, or while funding is available. Available trainings will be offered live via a web-based platform. Tuition and material costs are covered!

This opportunity is perfect for new staff that have joined your team who may need workshops (101–110) as well as the child welfare professionals who are ready to take the next step in their trauma-informed care education journey via completion of the Intensive Courses.

Trainings available include the following:

  • Enhancing Trauma Awareness;
  • Deepening Trauma Awareness;
  • Applying Trauma Principles;
  • Trauma-Sensitive Certification;
  • Train the Trainers;
  • Processing Pain, Facilitating Healing; and
  • Trauma 101 through 110 Workshops.

Interested in workshops? Visit here.   

Interested in the Intensive Courses? Visit here. 

Note: Participants who have completed Enhancing Trauma Awareness, Deepening Trauma Awareness, and Applying Trauma Principles should not take Trauma-Sensitive Certification, as content would be duplicated.

The simple distinction between certification as a Trauma-Sensitive Professional (TSC course) and Trauma-Competent Professional (ETA, DTA, and ATP) is:

  • Trauma-Competent Professional: Requires completion of 3 courses — Enhancing, Deepening, and Applying Trauma (75 hours) and 8 books for required outside reading. The courses must be taken in the order listed, and one must be completed before advancing to the next.
  • Trauma-Sensitive Professional: Requires completion of the course of the same name (50 hours) and 3 books for required outside reading. This certification covers fewer topics than the 75-hour course.

DO NOT DELAY for this exciting and FREE opportunity, and schedule your trauma trainings today!

If you have questions relating to any of these trainings, please submit them via email to Lakeside Global Institute.

The Office of Mental Health and Substance Abuse Services (OMHSAS) October 2023 Stakeholder Webinar is currently scheduled for Tuesday, 10/17/23 from 1:00 pm – 2:00 pm.

Please register here to participate. After registering, you will receive a confirmation email containing information about joining the webinar.

Call-in Number: 631-992-3221  •  Access Code: 332775346#

Please contact RCPA Mental Health Services Director Jim Sharp with any questions.

The Drug Enforcement Agency (DEA) issued a temporary rule extending the allowance for physicians and practitioners to prescribe controlled medications to new patients based on a relationship solely established through telemedicine (live video or telephone for buprenorphine) until December 31, 2024. The extension will give the DEA time to consider permanent changes to their rules around prescribing controlled substances moving forward.

Key concerns from stakeholders expressed during the listening sessions were related to in-person visit requirements, the 30-day prescribing limit in the initially proposed rules, and adding various reporting requirements, such as notating on prescriptions that they were prescribed via telemedicine. The rule itself lists additional reasons the extension is being issued:

  • “Prevent a reduction in access to care for patients who do not yet have an existing telemedicine relationship;
  • For relationships established both during the COVID-19 PHE and those established shortly after, prevent backlogs with respect to in-person medical evaluations in the months shortly before and after the expiration of the telemedicine flexibilities;
  • Address the urgent public health need for continued access to the initiation of buprenorphine as medication for opioid use disorder in the context of the continuing opioid public health crisis;
  • Allow patients, practitioners, pharmacists, service providers, and other stakeholders sufficient time to prepare for the implementation of any future regulations that apply to prescribing of controlled medications via telemedicine; and
  • Enable DEA, jointly with HHS, to conduct a thorough evaluation of regulatory alternatives in order to promulgate regulations that most effectively expand access to telemedicine encounters in a manner that is consistent with public health and safety, while also effectively mitigating against the risk of possible diversion.

RCPA will continue its advocacy work in partnering with the National Council on Mental Wellbeing to support the flexibility becoming part of reimagined legislation. Also, RCPA will continue its efforts on the current appeal it has filed with the DEA and OMHSAS to provide regulatory clarification on the licensing classification for those provider members who submitted applications for DEA Site Registration to disseminate Controlled Substances under the titled Act of 1970.

If you have questions, please contact RCPA Policy Director Jim Sharp.